First Drug to Treat Cushings Disease in Horses
The FDA announced approval of the drug Prascend to treat the clinical signs in horses with Equine Cushing's Disease.
Equine Cushings Disease usually affects horses in middle age or later life. Signs of the disease can include coat of long curly hair that does not shed properly, excessive water drinking and urination, abnormal fat distribution, muscle loss, excessive sweating, chronic laminitis, a compromised immune system which can lead to other illnesses.
In a 6 month field study, safety and effectiveness of the drug was successful in 86 of 113 horses treated. Common adverse effects of Prascend were poor appetite, lameness, diarrhea, colic and lethargy.
Prascend is manufactured for Boebringer Ingelheim Vetmedica Inc. of St.Joseph, Missouri.